Results 151 to 160 of about 21,470 (167)

Critical care management of chimeric antigen receptor T-cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Sandrine Valadè, Peter Schellongowski, Alexander Shimabukuro-Vornhagen   +2 more
exaly  

Chimeric antigen receptor T-cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Sagar Lonial, Rujul Parikh
exaly  

The antitumor activities of anti-CD47 antibodies require Fc-FcγR interactions

Cancer Cell, 2023
Juan C Osorio, David A Knorr, Jeffrey Ravetch   +2 more
exaly  

OncoImmunology

OncoImmunology, 2020
Wijnand Helfrich, Mark A J M Hendriks, Douwe F Samplonius   +2 more
exaly  

CD47-CAR-T Cells Effectively Kill Target Cancer Cells and Block Pancreatic Tumor Growth

Cancers, 2017
Vita Golubovskaya, Shirley Xu, Robert Berahovich   +2 more
exaly  

A bispecific antibody targeting CD47 and CD20 selectively binds and eliminates dual antigen expressing lymphoma cells

MAbs, 2015
Cyndhavi Narayanan, Ravindra Majeti, Kipp Weiskopf   +2 more
exaly  

CD47 fusion protein targets CD172a+ cells in Crohn’s disease and dampens the production of IL-1β and TNF

Journal of Experimental Medicine, 2013
Knut Schäkel, Nobuyasu Baba, Marika Sarfati   +2 more
exaly  

CD47 functions as a molecular switch for erythrocyte phagocytosis

Blood, 2012
Dirk de Korte, Robin van Bruggen, Timo K van den Berg   +2 more
exaly  

Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice

Journal of Experimental Medicine, 2012
Eugene Butcher, Sara Brownell, Siddhartha Jaiswal   +2 more
exaly  

The Vitronectin Receptor and its Associated CD47 Molecule Mediates Proinflammatory Cytokine Synthesis in Human Monocytes by Interaction with Soluble CD23

Journal of Cell Biology, 1999
Frederik P Lindberg, C Maliszewski, M Armant   +2 more
exaly